What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (4 Viewers)

The SAE argument still makes sense to me, isn't that something you want to substantially decrease for a better clinical outcome? Wouldn't other indicators align with this?

IDK, I want to punch that guy in his face.

 
He said this? I didn’t hear that part. 
 

Also don’t see any bump in the stock. 
I could be wrong but based on his usual demeanor, I took that to mean that he was upset at how many people died during the trial who could have been saved. Kind of a sad part of a drug trial if you find out the drug is effective. There will be a portion of the placebo group who die and might have lived if they weren’t randomly given the placebo. Anyway, he mentioned that before and that’s how I took it.

 
The SAE argument still makes sense to me, isn't that something you want to substantially decrease for a better clinical outcome? Wouldn't other indicators align with this?

IDK, I want to punch that guy in his face.
You are correct. You should see SAE go well down to be statistically relevant. The point being is that the drug should be doing more for people than just standard treatment.

 
I thought AF would have pre-written a hit piece on the stock dilution.
This is stock sleepy-time.  In an hour or so things start picking up, and would be a good time for some moves.  Shorting during a period of lethargy seems like it'd be futile.  Need some volume and some dupes.

 
I thought AF would have pre-written a hit piece on the stock dilution.
He’s already done that. To be honest, I would think that it’s built in even though it could be a surprise to some. That was one of the big hit pieces and short discussions when they filed the paperwork. Not saying it’s a non-event but I think everyone figured it’s a given. IMHO it’s not that big a deal unless they blow the shares/money. If you think about it, you are basically adding on to the current market cap the shares you sell. Your shares may be worth less but at the same time the company you own is now worth more. Anyway, I do think it’s basically bale in that it was happening.

 
#notselling

I believe there will be statistical significance with less adverse events than the current standard of care. It all comes down to this critical/severe trial. We need a treatment and it will be hard to deny this works if the data says so (primary endpoint is death at 28 days, pretty easy to determine if it was successful or not). This is what BP recommended as a frontline treatment. The facts are pretty clear at this point and I'll either go down with the ship, or this is going to help people with Covid.

So while my $40k can turn to $20k in the interim, if this trial is a success, I know it will more likely be $150k. I'm getting close to 4/1 and I have science on my side, I just need to watch the game unfold, which will absolutely be stressful. 

 
Also think the share dilution is built into the price.  I'm reading that NP said he wouldn't need more than 15m of the 100m approved, if that much.  Said NP plans to hold off until double digit stock price.  Someone said the extra funds will help in the Naz uplist in terms of the cash position requirement.  

 
To be fair, I work for a large company and they still constantly have issues when doing large conference calls. Hell, the last one was cancelled and they just recorded it to send it to everyone via email. 
I work for dhs and we have way more issues than this, even had the joints chief of staff on and that was a complete ####show, today was way better than any CG teleconference.

 
That dope needs to use the $ to hire a PR firm and some consultants who can present data.

I sold a bit less than 20% of my holdings, the only chunk I had in the black. 

I have zero confidence in this guy. The stock price is not where it's at because of him; it's where it's at because of BP and other stewards behind the scenes. And it would be higher were it not for him. I can't believe how bad this guy is. He's contentless, unaware, overly emotional, unprepared, obtuse. I can't for the life of me understand how he wound up in the position he's in (I don't want to research it as there's no upside).

So many things i want to know. Is Samsung Biologics actually manufacturing some inventory right now? We know NP said so, but are they? 

 
Can anyone confirm he actually has a PhD?
Been done, he does.  Again, he's been running the company reasonably well to position it to be where we are today.  Is he doing a great job from a PR perspective? Not that great, but he's had some good moments, has passion, but has lots of basic mistakes.  Hard to fault too much with the press release the other day in terms of what they could present...his biggest error is patience right now.  Underpromise, over-deliver.  He wants to keep everyone excited so he keeps over-extending, overpromising, and that's causing issues.  That's really the main issue I see with him is his constant desire to keep everyone excited, managing the excitement of everyone, responding to the shorting of stock, and the own-goals of setting unrealistic timelines.

Be patient, don't over-promise on timelines, let the data speak for itself and if there are wild fluctuations in pricing in the next few days/weeks, so be it.  At the end of the day, you have to conclude that the data/science will win, so just let it go.

 
Anyone daytrading CYDY right now?  It has a little bit of upward momentum.  $5.68

 
Last edited by a moderator:
Any update on the efficacy data? Or when it might be available?  
I think it's safe to bet not tomorrow or Friday.  Otherwise, NP would've hinted at it.  

He did say "days" but technically the year has 300+ of those so...i guess even a year from now could be days away.

 
Anyone daytrading CYDY right now?  It has a little bit of upward momentum.  $5.68
I day trade a lot in general.  Some days enough to make Bass look like a long term investor.  But I have never sold a share of The Chose Ticker.  I've bought more on dips, but never sold any.

 
Last edited by a moderator:
I day trade a lot in general.  Some days enough to make Bass look like a long term investor.  But I have never sold a share of CYDY.  I've bought more on dips, but never sold any.
Is it because you are planning on holding for a year for tax purposes?

 
Is it because you are planning on holding for a year for tax purposes?
It's more that I think I know my weaknesses.  I actually just posted about this in the "other" thread but my biggest weakness is stubbornness to buy something higher than I could have had it.

My biggest concern would be that I would do something stupid like sell a bunch with the intent of buying it back cheaper, only to see it go up.  Then in my stubbornness not being willing to pay more than I sold it for and trying to wait for a dip back to that number only to miss the big breakout in the interim.

It's not something I would worry about on a typical ticker but as I've mentioned before I am in CYDY for the upside and I've never felt that a huge upside play I was in was as legitimately possible as this one.  Nothing would crush me more than spending all this time on this ticker, having all of this confidence in it, and ultimately ending up being right but missing out on it because I was trying to trade for a few pennies here and there.

Pennies in front of a steamroller in reverse, kind of. 

 
Last edited by a moderator:
Volume is only 5 million at this point in the day.  What a sleepy, tired day.  Let's see if the last half hour is more lively.

 
Volume is only 5 million at this point in the day.  What a sleepy, tired day.  Let's see if the last half hour is more lively.
Crazy that a potential part of the solution to the corona riddle is getting so little movement from the market. 

 
So at this point, not really expecting much news until next week right?  Maybe the DSMC meeting, or announcement of the date for that?

Then an up-in-the-air release of the efficacy data sometime in the 'days' from now time period.

What else can move this stock?  More appearances from Dr. Patterson?  Anything expected?

 
So at this point, not really expecting much news until next week right?  Maybe the DSMC meeting, or announcement of the date for that?

Then an up-in-the-air release of the efficacy data sometime in the 'days' from now time period.

What else can move this stock?  More appearances from Dr. Patterson?  Anything expected?
Can’t see anything that will move it other than rumblings that the data is coming out in the AM or something similar. As great as BP is, I doubt many know who he is. Maybe if the big funds did some recent research and want to move before the news? 

 
So at this point, not really expecting much news until next week right?  Maybe the DSMC meeting, or announcement of the date for that?

Then an up-in-the-air release of the efficacy data sometime in the 'days' from now time period.

What else can move this stock?  More appearances from Dr. Patterson?  Anything expected?
The efficacy data for the M/M trial may weeks to fully complete.  The severe/critical trial is next up, imo.  There was talk about NP submitting the safety data from that trial next week to FDA (perhaps instead of a public PR... fingers crossed on that) and ask the FDA to provide emergency IND for those remaining patients.  

If this happens and the FDA approves, that could be really good.  People will quickly forget about the M/M lingering data.  That will come as well, but probably not next week.  

 
Saw this on another board:

SUMMARY OF SHAREHOLDERS MEETING:

CD-10 Phase II M/M Trial:

- Leron reduces SAEs in recipients by 64% (excellent results)
- No adverse effects attributable to Leron in those that received it
- Final results of this trial will take 6 weeks to complete from unblinding
- Results portend CytoDyn EUA in oncology use as well as COVID if Phase II
interim results are as good as expected. Huge!

CD-12 Phase III S/C Trial

- Complete data on 100 of current 153 patients available
- FDA can initiate a “safety review” of trial at any time to determine whether
to stop trial in order to save lives. I.E. Leron working so well, FDA does
not want to kill people given placebo in double blind test needlessly
- They would instead stop trial, give Leron EUA Authority and immediately
administer it to placebo patients


Cancer trials

- 23 different basket trials underway for Cancer.
- Many, including TNBC are showing excellent results in small enrollment
- CytoDyn will approach FDA for approval of several for EUA in September
pending previous approvals
- Trials are under independent analysis with no connection to CytoDyn

BLA for HIV

- CytoDyn has requested “Type A” meeting with FDA to resolve Refuse To File
problems (700mg dosage and inclusion of syringes in packaging)
- the meeting will occur “most likely next week” (Pourhassan speak)
- CytoDyn will report to shareholders the likely timeline of resolution after the
Type A meeting

New Hires to Scientific Advisory Board

- 4 new doctor hires in who are tops in their field regarding most promising
Cancer and HIV ongoing trials
- Hired to marshall/fine tune treatment in trials to maximize
potential for FDA approval of Leron in treatment of their specific disease
- New Hires include expertise in HIV bone marrow, breast cancer, pulmonary
lung transplant, blood cancers and NASH

- Not all have been hired just yet

Additional 100M Share Authorization (to total of 800M)

- Approved by 60+ % of shareholders
- Not yet necessary to use and would be used sparingly when done so
- have only used 15.7M shares this year thus far to fund operations
- 10M shares currently available for unforeseen needs outside of new shares
- $48M already raised this year through warrants (Nadar encouraged more)
to help fund ongoing endeavors
- $50 million more in warrants available at $5/share if they were exercised

NASDAQ UPLISTING

- 5-6 week process (we are completing week 2 on Friday)
- NASDAQ questions about filing ( if any) expected next week
- Week 5 or 6 most likely completion date (week 5 is mid-August)
- Nadar teased CFO Mike Mulholland about possibly completing filing
earlier. Chance it is done in 3-4 weeks

Final note - all timelines for major events are now in August and are not set in stone (good to prevent missed expectations and prevent short plays, imo). Very upbeat meeting, although presentation ranked up there with college frat house movie. Stock will drift along until we get further news and will likely face traditional daily day- trader fluctuations and occasional short attacks. I encourage all shareholders to hold the line as we longs enjoy the successes likely to come our way in August. There will be gut wrenching moments, but at the end of the day, DATA WINS! If you have any influence or skill you can bring to assist your fellow shareholders, now is the time to act. GLTA and anticipate much improved COMM going forward despite the charming and almost innocent nature of communications from CytoDyn to date.....
Nice summary of the meeting.

 
Last edited by a moderator:
He said that is the typical timeline for results like this. He didn't say it would take 6 weeks.... Am I the only one who didn't get that out of the call?
The other day, he said they typically take 4-6 weeks, and then something about seeing them yesterday possibly.  

 
He's waiting for a hit piece and a short attack before he releases them.  He wants to trap them.  The guy gets angry at anyone that would dare short the stock.
Gotta be honest, at first I hated this, but good, give them something to fear. Also, it seems to work when other CEOs take it personal (he sadly doesn't have the pedigree as most of those guys though).

 
Just wanted to make sure. He did mention other secondary endpoints (specifically, days in the hospital). 
However I do feel like sometimes (like trump) he goes off script to ad-lib. It’s possible somebody in the office sighed after he added the few days part. 

 
I'm going to guess they go corporate relatively soon.  We will all miss NP when he's relegated to just running the company and everything that comes out is corporately polished PR pieces with correctly spelled words in powerpoint, no impassioned diatribes against shorts, fewer anecdotes, less unrealistic deadlines...in short, we'll miss the NP when he's no longer front and center anymore.  And once they're uplisted to NASDAQ and have FDA approval for a product, I have a feeling they'll be stepping up their game in that respect.  Have no problem with NP as the leader of company, but as the PR guy he's not the best a multi-billion dollar company can offer.  But they're new money...give them a few weeks.

 
If the data isn’t out this week then it’s not good. They will wait for the severe hoping it’s better and bury the mild

 
If the data isn’t out this week then it’s not good. They will wait for the severe hoping it’s better and bury the mild
I'd give them until opening on Tuesday of next week before worrying too much.

Hard to believe it is released tomorrow if NP passed an opportunity to tease it.  Means Friday is likely in play but unlikely for the same reason.  I'd guess Monday morning at earliest, and if we haven't received an update by opening on Tuesday about its release or contents, I'll start worrying.  Until then, still no reason to doubt the science.

 
I'd give them until opening on Tuesday of next week before worrying too much.

Hard to believe it is released tomorrow if NP passed an opportunity to tease it.  Means Friday is likely in play but unlikely for the same reason.  I'd guess Monday morning at earliest, and if we haven't received an update by opening on Tuesday about its release or contents, I'll start worrying.  Until then, still no reason to doubt the science.
I agree with this timeline.  I think it's unlikely we see it this week.  I don't think they could hold onto it long enough to wait for the peak at the severe trial.  I think we wont get word of that until the first week of August.

 

Users who are viewing this thread

Back
Top